First-Line Pembrolizumab and Trastuzumab in HER2-Positive Esophageal, Gastric, or Gastroesophageal Junction Cancer
Patients with Her2-positive gastric cancer taking a combination of the immune-boosting drug Keytruda with Herceptin had progression-free survival rate at six months... Read More
Regorafenib Plus Nivolumab in Patients With Advanced Gastric or Colorectal Cancer
A recent trial of a combination of Stivarga and Opdivo showed better activity than either drug alone in patients with gastric cancer.
FDA Grants Full Approval of Deciphera Pharmaceuticals’ QINLOCK™ (ripretinib) for the Treatment of Fourth-Line Gastrointestinal Stromal Tumor
The FDA approved Deciphera Pharmaceuticals’ Quinlock (ripretinib) for the treatment of advanced gastrointestinal stromal tumors.
ctDNA Identifies Acquired Resistance Mechanisms to Savolitinib in MET+ Gastric Cancer
An early trial of AstraZeneca’s MET inhibitor savolitinib in gastric cancer revealed mutations that confer drug resistance.
GCF-AGA Grant Awards Newest Research Scholar: Samuel J Klempner, MD
Samuel J. Klempner, M.D., was completing his fellowship at Beth Israel Deaconess Medical Center in Boston when he first became interested in... Read More
Enhertu granted Orphan Drug Designation in the US for gastric cancer
AstraZeneca and Daiichi Sankyo won breakthrough designation and orphan drug designation from the FDA for Enhertu in treating HER2-positive gastric cancer, which... Read More
ASCO: In stomach cancer, AstraZeneca and Daiichi’s Enhertu goes where Roche’s Kadcyla couldn’t
In a pivotal study, patients taking Enhertu from AstraZeneca and Daiichi Sankyo saw their tumors shrink and were still alive after a... Read More
Older versus younger adults with gastric cancer receiving perioperative treatment: Results from the CRITICS trial
A new study finds that compliance to treatments prescribed after surgery is worse in older adults being treated for gastric cancer than... Read More
Hispanic/Latino gastric adenocarcinoma patients have distinct molecular profiles including a high rate of germline CDH1 mutations
Gene sequencing revealed a high rate of mutations that raise the risk of gastric cancer among people of hispanic origins, according to... Read More
Oesophageal and proximal gastric adenocarcinomas are rare after detection of Helicobacter pylori infection
A study of more than 36,000 people with H. pylori raises questions about the long-held belief that eradicating the infection lowers the... Read More